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ABSTRACT
The transcription-repair coupling factor (TRCF, the
product of the mfd gene) is a widely conserved
bacterial protein that mediates transcription-
coupled DNA repair. TRCF uses its ATP-dependent
DNA translocase activity to remove transcription
complexes stalled at sites of DNA damage, and
stimulates repair by recruiting components of the
nucleotide excision repair pathway to the site. A
protein/protein interaction between TRCF and the
b-subunit of RNA polymerase (RNAP) is essential
for TRCF function. CarD (also called CdnL), an
essential regulator of rRNA transcription in
Mycobacterium tuberculosis, shares a homologous
RNAP interacting domain with TRCF and also inter-
acts with the RNAP b-subunit. We determined the
2.9-A ˚ resolution X-ray crystal structure of the
RNAP interacting domain of TRCF complexed with
the RNAP-b1 domain, which harbors the TRCF inter-
action determinants. The structure reveals details of
the TRCF/RNAP protein/protein interface, providing
a basis for the design and interpretation of experi-
ments probing TRCF, and by homology CarD,
function and interactions with the RNAP.
INTRODUCTION
Transcribing RNA polymerase (RNAP) molecules stalled
at sites of DNA damage elicit preferential repair of the
DNA in a process called transcription-coupled repair
(TCR) (1,2). Paradoxically, the stalled RNAP molecules
are inhibitory to DNA repair in vitro (3), pointing to the
role of additional factors mediating TCR in vivo.I n
bacteria, transcription-repair coupling factor (TRCF),
the product of the mfd gene (4,5), was shown to be neces-
sary and sufﬁcient for TCR in vivo and in vitro. TRCF
plays two key roles in mediating TCR: (i) relief of
transcription-dependent inhibition of nucleotide excision
repair (NER) by recognition and ATP-dependent removal
of a stalled RNAP covering the damaged DNA and
(ii) stimulation of DNA repair by recruitment of the
Uvr(A)BC endonuclease (3,6,7)
TRCF is a large (130kDa), evolutionarily conserved,
multi-functional protein with a complex structure/
function relationship. The 3.2-A ˚ resolution X-ray crystal
structure of Escherichia coli (Eco) TRCF comprises a
compact arrangement of eight structured domains [D1a,
D1b and D2–D7) linked by ﬂexible linkers (8); Figure 1A].
These domains are arranged in functional modules that
perform the various TRCF functions. Recruitment of
the NER machinery through binding of the NER compo-
nent UvrA is accomplished by the TRCF UvrB homology
module (D1a, D1b and D2) (6,8–10). RNAP binding is
mediated by the TRCF RNAP interacting domain [RID;
(8)]. The ATP-dependent double-stranded DNA
translocase activity is due to the translocation module
[TD1 and TD2; (8)], which contains the seven signature
sequence motifs of superfamily 2 helicases/ATPases (11).
All of these activities are repressed in isolated TRCF
through an interdomain interaction between D2 and the
C-terminal D7 domain (12,13).
Critical among the TRCF functional modules
is the RID, a Tudor-like domain that mediates protein/
protein interactions between TRCF and RNAP that are es-
sential for the RNAP release function (8,14) (Figure 1A).
The interaction between the TRCF–RID and
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bar represents the 1148-residue Eco TRCF primary sequence (every 100 residues are marked below the bar). Structural domains are represented as
thick, colored bars; thin black bars represent linkers connecting the domains (8). The RID is highlighted and colored magenta. Below the bar, a side
view of the structure of repressed Eco TRCF (8) is shown as an a-carbon backbone, with the domains color-coded as in the bar above. The RID
Continued
8358 Nucleic Acids Research, 2010,Vol.38, No. 22RNAP: (i) recruits TRCF to the site of the stalled RNAP;
(ii) is thought to trigger the conformational changes
associated with derepression of the TRCF activities (8)
and (iii) provides an anchor for TRCF on RNAP,
allowing the TRCF DNA-tracking translocation activity
to exert forces on the DNA that are thought to cause
collapse of the transcription bubble within the RNAP
ternary elongation complex (TEC), resulting in RNAP
and transcript release (15).
Taken together, biochemical, as well as yeast and bac-
terial two-hybrid analyses have identiﬁed an RNAP
b-subunit segment, Eco b residues 19–142 (b
19–142), as
being sufﬁcient for TRCF–RID interaction (8,14,16).
Amino acid substitutions in both the TRCF–RID
(Eco TRCF
L499R) and in the RNAP b-subunit
(Eco b I117A, K118A or E119A) disrupt the TRCF/
RNAP protein/protein interaction and cause defects in
the RNAP release activity of TRCF (8,14).
The TRCF–RID is homologous to a domain widely
distributed in bacteria (17) and grouped as the
CarD_TRCF protein family (Pfam: PF02559). CarD
(also called CdnL) (18) is an essential regulator of
rRNA transcription in Mycobacterium tuberculosis (Mtb)
that is upregulated in the general stress response and plays
a key role in persistence and pathogenesis (19). The CarD
N-terminal domain (NTD) shares striking sequence
homology with the TRCF–RID and interacts with the
RNAP b-subunit in the same manner (18,19).
In this work, we determined a 2.9-A ˚ resolution X-ray
crystal structure of a complex between the Thermus
thermophilus TRCF–RID and the T. aquaticus (Taq)
RNAP b-subunit b1 domain (which harbors the TRCF–
RID interaction determinant). The details of the protein/
protein interface explain the effects of amino acid substi-
tutions in both the TRCF–RID (8) and the RNAP-b1
domain (8,14) that cause defects in the protein/protein
interaction, and guides the design of new substitutions
tested herein to further elucidate the interaction. The struc-
ture also reveals a local conformational change in the b1
domain upon binding the TRCF–RID. This work provides
a basis for the design and interpretation of experiments
probing TRCF function and interactions with the
RNAP, as well as the function and RNAP interactions of
other members of the CarD_TRCF protein family.
MATERIALS AND METHODS
Construction of expression plasmids for Tth TRCF–RID
and Taq RNAP-b1
The DNA encoding Tth HB27 TRCF–RID (residues
321–387) was ampliﬁed by the polymerase chain reaction
(PCR) using primers that appended NdeI and HindIII
sites at the 50- and 30-ends, respectively. The PCR-
ampliﬁed DNA fragment was cleaved with NdeI
and HindIII and cloned between the NdeI and HindIII
sites of a pET28a-derived plasmid, creating pET28a
TthHB27(His)6MfdRID. PCR was used to amplify and
fuse the DNA encoding Taq b1a (Taq b
17–139) and
b1b (Taq b
334–395). Primers were designed to introduce
a –Gly–Gly– linker between the two b1 segments and
NdeI and BamHI restriction endonuclease sites were
appended to the 50- and 30-ends of the fused DNA
fragment, respectively. The resulting DNA fragment was
cleaved with NdeI and BamHI and cloned between the
same sites of pET21a (Novagen), creating pET21a Taq
b1. All DNA manipulations were conﬁrmed by DNA
sequencing.
Expression and puriﬁcation of the TthTRCF–RID/Taq
RNAP-b1 complex
The plasmids pET21a Taq b1 and pET28aTth HB27Mfd-
RID were transformed simultaneously into Eco BL21
(DE3) cells (Novagen) and transformants were grown
at 37 C in Luria–Bertani media supplemented with ampi-
cillin (200mg/ml) and kanamycin (50mg/ml) to an A650 nm
between 0.6 and 0.8. Subsequently, ampicillin (100mg/ml)
and isopropyl-b,D-thiogalactopyranoside (1mM ﬁnal
concentration) were added to the culture. After incubation
at 37 C for 3h, the cells were harvested by centrifugation,
resuspended in buffer A [20mMTris–HCl (pH 8.0 at 4 C),
200mM NaCl, 5%(v/v) glycerol, 0.5mM b-merca-
ptoethanol], lysed using a continuous-ﬂow homogenizer
(Avestin), and then centrifuged to remove insoluble
Figure 1. Continued
(Eco TRCF
479–545, colored magenta) is highlighted with a transparent molecular surface. L499 is shown as pink CPK atoms; an L499R substitution
at this position disrupts the TRCF–RID/RNAP protein/protein interaction (8). (Upper right) The horizontal bar represents the N-terminal 400
residues of the Taq RNAP b-subunit primary sequence (every 100 residues are marked below the bar). Structural domains are represented as thick,
colored bars, thin black bars represent linkers connecting the domains (25,26). The two sequence elements comprising the b1 domain (b1a, residues
17–139, and b1b, residues 334–395), which ﬂank the b2 domain, are highlighted and colored cyan. Below the bar, the b-side view of the structure of
Taq core RNAP (26) is shown as an a-carbon backbone and with the subunits color-coded as follows: aI, aII, gray; b, pale cyan, except the b1
domain is cyan; b0, pale pink. The b1 domain is also highlighted with a transparent molecular surface. The b2 domain is also denoted. b residues
I108, K109, and I110 are shown as green CPK atoms; substitutions at corresponding positions in the Eco RNAP b-subunit (Eco
RNAP-b
I117,K118,E119) cause defects in the TRCF/RNAP protein/protein interaction (8,14). (Middle) The structure of the Tth TRCF–RID/ Taq
RNAP-b1 complex, shown as a ribbon diagram (Tth TRCF–RID, magenta; Taq RNAP-b1, cyan). In the TRCF–RID, the a-carbon of R341 is
shown as a pink sphere; Tth TRCF–RID
R341 corresponds to Eco TRCF–RID
L499, which has been shown to be involved in the TRCF–RID/RNAP
protein/protein interface (8). In the RNAP-b1, the a-carbons of I108, K109 and E110 are shown as green spheres; Taq RNAP-b1
I108,K109,E110
correspond to Eco RNAP-b1
I117,K118,E119, which have been shown to be involved in the TRCF–RID/RNAP protein/protein interface (8,14). The
–Gly–Gly– linker, introduced into the construct to connect b1a and b1b, is colored grey and shown as a-carbon spheres. (B) Topology diagram of
the Tth TRCF–RID/ Taq RNAP-b1 complex; a-helices are shown as rectangles, b-strands as arrows. The start- and end-residues for each secondary
structural element are shown. The b-strands involved in the intermolecular b-sheet formed in the complex are numbered for each protein. The
TRCF–RID is colored magenta, but b-strand 1 and b-strand 5, disordered in all four heterodimers of the crystallographic asymmetric unit, are
shown in pink. The location of the interface residue R341 is shown as a pink circle. The RNAP-b1 domain is colored cyan. The locations of the
interface residues I108, K109 and E110 are shown as green circles.
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2+-
charged HiTrap column (GE Healthcare) equilibrated in
buffer A+5mM imidazole. The column was washed with
ﬁve column volumes (cv) of buffer A+20mM imidazole,
5cv buffer A+40mM imidazole, 5cv buffer A+60mM
imidazole and ﬁnally 5cv buffer A +80mM imidazole.
Proteins bound to the column were eluted with buffer
A+250mM imidazole. After overnight cleavage with
PreScission protease (GE Healthcare) to remove the
(His)6-tag and dialysis against buffer A+5mM imidazole,
a subtractive Ni
2+-chelating chromatographic step
removed uncleaved (His)6TRCF–RID and the cleaved
(His)6-tag. The sample was concentrated and applied to
a Superdex 75 gel ﬁltration column (GE Healthcare).
Finally, the puriﬁed sample was concentrated to
10.6mg/ml and exchanged into storage buffer (10mM
Tris–HCl[pH 8.0 at 4 C], 100mM NaCl, 5mM DTT).
The purity of the complex was judged to be >95% as
analyzed by sodium dodecyl sulfate polyacrylamide gel
electrophoresis and Coomassie blue staining (data not
shown).
Crystallization and structure determination
Crystals were grown by hanging-drop vapor diffusion by
mixing 2ml protein solution (10–12mg/ml in storage
buffer) with 1ml crystallization solution (0.1M Tris–HCl
[pH 7.5 at 22 C], 1.6M di-potassium ammonium phos-
phate), and incubating over a well containing crystalliza-
tion solution. Crystals (10–20mm octahedra) grew in
 1 week. The crystals were prepared for cryo-
crystallography by stepwise transfer into 0.1M Tris–HCl
[pH 7.5 at 22 C], 100mM NaCl, 7M ammonium formate,
then frozen in liquid nitrogen. X-ray diffraction data sets
(Table 1) were collected at the Advanced Photon Source
(Argonne National Laboratory) NE-CAT 24-ID-E
beamline, using an MD-2 microdiffractometer with a
20mm aperture. Because of the small size of the crystals,
the data quality degraded before a full data set from a
single crystal could be collected, but partial data sets
were collected from nine separate crystals. The crystals
appeared to belong to space group P43212, but subsequent
analysis indicated the crystals were hemihedrally twinned
and belonged to space group P43. One data set was chosen
as a reference (crystal a, Table 1). The additional data sets
were processed in two orientations (h, k, l and  h, k,  l),
and were then combined, one at a time, and kept or dis-
carded, depending on whether the overall data improved,
resulting in the ﬁnal combined data set from partial data
sets collected from three separate crystals (Table 1).
Using the structure of the Taq RNAP-b1( Taq
RNAP-b
[17–195 and 334–395]) as a search model, a molecular
replacement solution containing four copies in the asym-
metric unit was obtained using CNS (20). Additional mo-
lecular replacement searches to locate the TRCF–RID,
using a homology model of the Tth TRCF–RID based
on the Eco TRCF–RID (8) as a search model, using
either CNS or BRUTEPTF (21) were unsuccessful.
Nevertheless, maps phased from the Taq RNAP-b1 mo-
lecular replacement solution alone, combined with density
Table 1. Data collection and reﬁnement statistics (molecular replacement)
a b c Comb (a,b,c)
Data collection
Space group P43
a P43
a P43
a P43
a
Cell dimensions
a/b, c (A ˚ ) 106.55, 122.23 106.19, 120.76 106.32, 120.74 106.59, 122.30
Resolution (A ˚ ) 30.0 2.90 (3.00 2.90) 30.0 2.90 (3.00 2.90) 30.0 2.90 (3.00 2.90) 30.0 2.90 (3.00 2.90)
Rsym or Rmerge 0.063 (0.340) 0.063 (0.423) 0.064 (0.521) 0.088 (0.501)
I/sI 9.98 (1.35) 10.0 (1.31) 11.2 (1.30) 14.1 (1.80)
Completeness (%) 58.4 (60.0) 56.9 (58.3) 46.3 (47.6) 91.3 (92.4)
Redundancy 1.2 (1.1) 1.3 (1.2) 1.2 (1.2) 2.2(2.1)
Reﬁnement
Resolution (A ˚ ) 30.0 2.90
No. reﬂections 25538
Rwork/Rfree
b 0.228/0.250
No. atoms 6868
Protein 6863
Ligand/ion 5(1 PO4  ion)
Water 0
B-factors
Protein 52.02
Ligand/ion 53.78
Rmsd
Bond lengths (A ˚ ) 0.008
Bond angles ( ) 1.236
Ramachandran plot
c
Favored (% residues) 90.7
Allowed (% residues) 9.3
Disallowed (% residues) 0
aThe crystals are P43 but are hemihedrally twinned and appear to be P43212, with twin operator  h, k,  l and twin fraction 0.478.
bTwinned Rwork/Rfree from Refmac5 (22).
cDetermined using PROCHECK (46).
8360 Nucleic Acids Research, 2010,Vol.38, No. 22modiﬁcation using CNS, revealed clear electron density
for the TRCF–RIDs (Supplementary Figure S1A). After
iterative rounds of building and minimization to 2.9A ˚ , the
ﬁnal model was reﬁned to an R/Rfree of 0.228/0.250 using
Refmac5 (22). Initial rounds of reﬁnement incorporated
tight non-crystallographic symmetry (NCS) restraints
(with two NCS groups, the TRCF–RID and RNAP-b1).
Final rounds kept loose NCS restraints and also utilized
TLS reﬁnement (with two TLS groups, the TRCF–RID
and RNAP-b1).
Bacterial two-hybrid assays
Plasmids pAC  CI-Eco b, pAC  CI-Eco TRCF, pAC
 CI-Tth b and pAC  CI-Tth TRCF encode residues
1–236 of the bacteriophage  CI protein fused to residues
19–142 of the Eco RNAP b-subunit, residues 472–603 of
Eco TRCF, residues 10–133 of the Tth RNAP b-subunit
or residues 314–444 of Tth TRCF, respectively, under
the control of the IPTG-inducible lacUV5 promoter.
Plasmids pBR a-Eco b, pBRa-Eco TRCF, pBRa-Tth b
and pBRa-Tth TRCF encode residues 1–248 of the Eco
RNAP a-subunit fused to residues 19–142 of the Eco
RNAP b-subunit, residues 472–603 of Eco TRCF,
residues 10–133 of the Tth RNAP b-subunit or residues
314–444 of Tth TRCF, respectively, under the control
of tandem lpp and IPTG-inducible lacUV5 promoters (8).
Substitutions Tth RNAP-b1
Q99R, Tth TRCF–RID
R341L,
Eco TRCF–RID
L499R, Eco RNAP-b1 R101Q and
R101 E, were introduced into the appropriate plasmid by
PCR. Plasmid pBRa encodes wild-type a and plasmid
pAC CI encodes the bacteriophage  CI protein (23).
FW102 OL262 reporter strain cells were transformed
with the indicated plasmids. Individual transformants
were selected and grown in LB supplemented with
carbenicillin (100mg/ml), kanamycin (50mg/ml), chloram-
phenicol (25mg/ml), and the indicated concentration of
IPTG. b-galactosidase assays were performed as described
earlier (24) using microtitre plates and a microtitre plate
reader. b-Galactosidase activity (reported as Miller Units)
was calculated as described earlier (24).
RESULTS
Crystallization and structure determination of
TRCF–RID/RNAP-b1
The TRCF/RNAP protein/protein interaction was dis-
covered and characterized studying the Eco system
(8,10,14). Nevertheless, biochemical experiments suggested
thattheEcoTRCF–RID/RNAP-b1complexwasrelatively
unstable and might not be suitable for structural studies.
For instance, while we could detect and study the Eco
TRCF–RID/RNAP-b1 interaction using the highly sensi-
tive bacterial two-hybrid system, we did not observe a
stable interaction in vitro using typical biochemical
methods, such as afﬁnity isolations (8). However, in other
experiments, we observed evidence for robust interaction
between Tth TRCF and Tth RNAP (L.F. Westblade, B.T.
Chait and S.A. Darst, unpublished data), suggesting that
the Thermus TRCF–RID/RNAP-b1 interaction is suitably
stable for X-ray crystallographic studies. The two protein
domains are well conserved; the Tth TRCF–RID is
40% identical in sequence to the Eco TRCF–RID and
the Thermus RNAP-b1 domain is 50% identical to
Eco RNAP-b1 (Figure 2A). We chose to crystallize the
complex of only the protein domains required
for the TRCF/RNAP protein/protein interaction
(i.e. the Tth TRCF–RID and Taq RNAP-b1 domains) to
increase the chances of obtaining crystals of the complex
that diffract to high resolution.
While the RNAP-b1 domain is a well-folded structural
domain with a distinct hydrophobic core, a complication
for our strategy was that the b1 structural domain is not
contiguous in the RNAP b-subunit sequence. In Thermus
RNAP, the b1 domain comprises b residues 17–139 (b1a)
and 334–395 [b1b; (25,26)]. The RNAP mutants that
disrupt the TRCF/RNAP protein/protein interaction
(Eco b
117–119/Tth b
108–110) (8,14) lie in the larger b1a, but
this segment alone is unlikely to form a stable, well-folded
domain suitable for structural studies. Fortunately, within
the RNAP structure, the C-terminus of b1a (residue 139)
and the N-terminus of b1b (residue 334) are only 5.4A ˚
apart (Ca–Ca distance), allowing them to be connected by
a –Gly–Gly– linker. We therefore sub-cloned the Tth
TRCF–RID (Tth TRCF
321–387) into a pET28a-based
co-expression cassette (27) along with the –Gly–Gly–
linked segments of the Taq RNAP-b1 domain (Taq
RNAP-b
[17–130]–GG–[334–395]), or expressed the two
proteins simultaneously from separate plasmids. The
Taq and Tth RNAP-b1 domains are 93% identical/98%
homologous over 185 residues, and all of the b1 residues
that interact with the TRCF–RID are identical between
Taq and Tth (Figure 2A).
Upon co-expression, both the Tth TRCF–RID and the
–Gly–Gly– linked segments of the Taq RNAP-b1 domain
assembled into a stable, soluble complex that was puriﬁed
and crystallized as small (15–20mm width) octahedra.
SDS–PAGE and mass-spectrometric analyses conﬁrmed
that the crystals contained both proteins. Subsequent op-
timization procedures yielded slightly larger crystals
(25mm width). Despite the small size of the crystals,
X-ray diffraction to  5A ˚ -resolution was observed at
various synchrotron sources, where the smallest achiev-
able beamsize was  50mm in diameter. Diffraction data
<3A ˚ -resolution was collected at a microdiffractometer
beamline, using a collimated 20mm diameter beam.
Individual crystals succumbed to radiation damage
before complete data sets could be collected, but a data
set to 2.9-A ˚ resolution was obtained by combining partial
data sets from three separate crystals (Table 1).
The hemihedrally twinned crystals belong to the space
group P43. The structure was solved by molecular replace-
ment using the Taq RNAP-b1 fragment as a search model.
Four solutions were eventually found, consistent with four
copies of the heterodimeric complex in the asymmetric
unit. Additional molecular replacement searches including
a homology model of the Tth TRCF–RID (20,28), and
even ‘brute-force’ phased translation searches (21) failed
to position the TRCF–RID. Nevertheless, electron density
maps calculated from the RNAP-b1 molecular replace-
ment solution alone showed good density corresponding
to the TRCF–RID (Supplementary Figure S1A).
Nucleic Acids Research, 2010,Vol.38, No. 22 8361Figure 2. Sequence and structural features of the TRCF–RID/RNAP-b1 interface. (A) Sequence conservation in the TRCF–RID/RNAP-b1 inter-
face. Sequences are shown in one-letter amino acid code and identiﬁed by species at the left. The numbers at the beginning of each line indicate
amino acid positions relative to the start of each protein sequence. Residues involved in direct interprotein contacts in the TRCF–RID/RNAP-b1
interface are denoted by colored dots directly above the sequences. The locations of b-strands are denoted schematically above the sequences. The
numbers above indicate the amino acid position in Tth TRCF and RNAP-b. Positions in the alignment that share >50% identity with the consensus
are indicated by red shading, while positions that share >50% homology are indicated by blue shading. Homology groups are deﬁned as: a, acidic
(DE); b, basic (HKR); f, aliphatic (AGILV); m, amide (NQ); o, aromatic (FWY), h, hydroxyl (ST); i, imino (P); s, sulfur (CM). Shown at the very
top is the consensus homology, and the strength of the homology shown in a histogram (tall red bar, 100% homologous, short blue bar, <20%
homologous). The positions correlated between the TRCF–RID and RNAP-b1 are highlighted in cyan/green). If the position corresponding to
Tth TRCF–RID
R341 is R, then the position corresponding to Tth RNAP-b1
Q99 is Q or E (cyan). On the other hand, if the TRCF–RID residue is I,
L, V, or E, then the RNAP-b1 residue is R (green). (B) Molecular structure of the TRCF–RID/RNAP-b1 interface. The TRCF–RID is shown as a
pale pink backbone worm. Residues involved in direct contacts with RNAP-b1 are shown in stick format (nitrogen atoms, blue; oxygen, red; carbon,
magenta, except R341 is pink). The RNAP-b1 is shown as a pale cyan backbone worm. Residues involved in direct contacts with the TRCF–RID are
shown in stick format (nitrogen atoms, blue; oxygen, red; carbon, cyan, except I108, K109 and E110 are green). Polar contacts are shown as dashed
lines (backbone–backbone hydrogen bonds, red; side-chain polar contacts, grey). (C) Schematic diagram illustrating TRCF–RID/RNAP-b1 inter-
molecular contacts: yellow lines, van der Waals contacts (<4A ˚ ); green lines, hydrogen bonds (<3.2A ˚ ); red lines, salt bridges/hydrogen bonds. Note
that the TRCF–RID is shown with the C-terminus at the top, while the RNAP-b1 is shown with the N-terminus at the top.
8362 Nucleic Acids Research, 2010,Vol.38, No. 22An atomic model of the TRCF–RID/RNAP-b1 complex
was built and reﬁned to a twinned R/Rfree of 0.228/0.250 at
2.9-A ˚ resolution (Table 1 and Figure 1A).
Overall structure
The TRCF–RID/RNAP-b1 structure reveals the expected
1:1 heterodimer (Figure 1). The four crystallographically
independent heterodimers are all very similar in structure;
the maximum root-mean-square-deviation (rmsd) in
a-carbon positions when comparing 190 positions within
well-deﬁned regions of the structure (excluding ﬂexible
loops) was 0.41A ˚ .
The two proteins engage in a complex involving inter-
faces containing the residues found previously to be im-
portant for the protein/protein interaction. This includes
Tth TRCF–RID
R341 [corresponding to Eco TRCF–
RID
L499; (8)] and Taq RNAP-b1
I108/K109/E110 [correspond-
ing to Eco RNAP-b1
I117/K118/E119; (8,14)] (Figures 1, 2A
and B). Formation of the complex results in the burial of a
modest 555A ˚ 2 of otherwise exposed surface area.
The structural core of the RNAP-b1 domain can be
described as a four-stranded antiparallel b-sheet but-
tressed on one face by a-helices (Figure 1). The TRCF–
RID comprises a Tudor-like fold, a highly bent,
ﬁve-stranded antiparallel b-sheet that folds into a
barrel-like roll (8). The C-terminal b-strand of the
b1 domain (b1 b-strand 4, Figure 1B) and the penultimate
TRCF–RID b-strand (TRCF–RID b-strand 4,
Figure 1B), are exposed at the edge of the individual
domain structures (Figure 1). In the TRCF–RID/
RNAP-b1 complex, these two edge-exposed b-strands
interact to form an antiparallel, intermolecular b-sheet
that extends across the two separate proteins (Figure 1).
The Tth TRCF–RID in the TRCF–RID/RNAP-b1
complex is very similar in structure to the Eco TRCF–
RID, except that the N-terminal and C-terminal
b-strands (TRCF–RID b-strand 1 and b-strand 5,
Figures 1B and 3A) are disordered in all four crystallo-
graphically independent copies of the Tth TRCF–RID.
Thus, the extended, intermolecular b-sheet in the TRCF–
RID/RNAP-b1 complex comprises seven b-strands, rather
than the expected nine (Figures 1B, 3A). Analysis of the
TRCF–RID/RNAP-b1 structure indicates that the inter-
molecular crystal packing is incompatible with the
presence of the TRCF–RID b-strand 1 and b-strand 5
(Supplementary Figure S2), suggesting that crystal
packing forces induced partial unfolding of the TRCF–
RID. This may explain the small size of the crystals.
Superimposition of the ordered portion of the Tth
TRCF–RID with the Eco TRCF–RID yields an rmsd of
1.15A ˚ over 32 a-carbon positions (Figure 3A).
Although the overall structure of the RNAP-b1 domain
in the TRCF–RID/RNAP-b1 complex is similar to
the RNAP-b1 domain in the context of RNAP (rmsd
of 0.97A ˚ over 114 well-deﬁned a-carbon positions;
Figure 3B), a signiﬁcant, local conformational change
was observed (Figure 3B–E). The conformational change
entails a ‘register shift’ of b1 b-strand 4 with respect to
b-strand 3 (Figure 3B–E). In all available bacterial RNAP
structures, the register of the b1 domain b-sheet is such
that L98 pairs with E110 (L98:E110) and L100:I108
(Figure 3D and E, left). In the b-side view of the RNAP
(looking down on the b-subunit from outside the active
site channel, the perspective seen in Figure 3D and E), the
side-chains of I108 and E110 point down away from the
viewer, while the side-chain of K109 points up towards the
viewer (Figure 3D and E, left). On the other hand, in the
complex with the TRCF–RID, the register is such that
L98:D111 and L100:K109. The side-chains of I108 and
E110 now point up towards the viewer, while K109
points down away from the viewer (Figure 3D and E,
right). The overall register shift involves residues
103–111. In the RNAP without TRCF, E110 or D111 is
‘pinched out’ of b1 b-strand 4, while in the complex with
TRCF, these residues are incorporated into the b-strand
(Figure 3D and E). The shift in b1 b-strand 4 is
accommodated in the ﬂexible loop connecting b-strand 3
and b-strand 4 (residues 103–105). Since this is an unusual
conformational change and the resolution of our analysis
(2.9A ˚ ) is modest, we performed test reﬁnements in which
the RNAP-b1 b-strand 4 register was modeled as in the
available RNAP structures. The results of these tests con-
ﬁrmed that the RNAP-b1 b-strand 4 register shift was not
the result of a mistracing (Supplementary Data).
Although this conformational change is very localized,
it must play an important role in the TRCF–RID inter-
action with the RNAP b1 domain, since the residues
involved in the shift and reorientation are exactly the
residues of RNAP that make critical interactions with
the TRCF–RID, corresponding to Thermus I108, K109
and E110. We presume that the RNAP-b1 ﬂuctuates
normally between these two conformational states,
and that the TRCF–RID binds to and stabilizes the
state observed in the TRCF–RID/RNAP-b1 structure
(Figure 3D and E, right).
TRCF–RID/RNAP-b1 interface
The predominant interaction in the TRCF–RID/
RNAP-b1 interface occurs across the extended, intermo-
lecular b-sheet and involves van der Waals as well as poly-
peptide backbone hydrogen bonding between RNAP-b1
bstrand4 and TRCF–RID bstrand4 (Figures 1 and 2). On
the b1 domain, this interface extends from Taq RNAP-b1
G106 to E110, and includes the three RNAP residues
shown to be important for the TRCF–RID/
RNAP protein/protein interaction, corresponding to
Thermus I108/K109/E110 (8,14). On the TRCF–RID,
this interface extends from Tth TRCF–RID G359 to
P364. TRCF–RID residues 361–364 comprise a
well-conserved motif, f-o-f-P, where ‘f’ stands for hydro-
phobic aliphatic residue (I, L or V), and ‘o’ stands for
aromatic (Y or F) (Figure 2A) (8). TRCF–RID b-strand
2 and b-strand 3 extend past the end of TRCF–RID
b-strand 4 and arch over the top of the RNAP-b1
domain, affording additional interactions. Y350 (from
TRCF–RID b-strand 3) is highly conserved as an
aromatic residue (Figure 2A), and makes van der Waals
contacts with RNAP-b
I108. Finally, TRCF–RID
R341
(from TRCF–RID b-strand 2) makes polar contacts
with RNAP-b E110 as well as with Q99 (Figure 2).
Nucleic Acids Research, 2010,Vol.38, No. 22 8363Figure 3. Structural comparisons. (A) Comparison of the Eco TRCF–RID (residues 479–545 from the Eco TRCF structure; (8), colored as a ramp
from blue (N-terminus) to red (C-terminus), and the Tth TRCF–RID (colored magenta) from the TRCF–RID/RNAP-b1 complex. The secondary
structure of the two proteins is shown in schematic form on top. Below, the superimposed TRCF–RID structures are shown as ribbon diagrams,
color-coded as in the schematic. The Taq RNAP-b1 complexed with Tth TRCF–RID is also shown. (B) Comparison of the Taq RNAP-b1 domains
from the Taq core RNAP (pale cyan) (26), and from the TRCF–RID/RNAP-b1 complex (cyan). The superimposed structures are shown as
backbone worms. The a-carbons of the TRCF–RID interface residues I108, K109, and E110 are shown as spheres (RNAP, yellow; complex with
TRCF–RID, green), illustrating the register shift. (C) Side view of RNAP-b1 residues 102–112 from the RNAP structure (pale cyan, but with I108/
K109/E110 colored yellow) and from the TRCF–RID/RNAP-b1 structure (cyan, but with I108/K109/E110 colored green), illustrating the register
shift. The structures were aligned over the entire b1 domain. (D) Top view of RNAP-b1 b-strand 3 and b-strand 4 from the RNAP structure.
Backbone-backbone hydrogen bonding interactions are shown as dashed grey lines. Below is the same, shown as a schematic. The dark-colored
triangles denote side chains that point away from the viewer, down into the plane of the page. The light-colored triangles denote side chains that
point up towards the viewer, out of the plane of the page. (E) Top view of RNAP-b1 b-strand 3 and b-strand 4 from the TRCF–RID/RNAP-b1
structure. Also shown are TRCF–RID
360–362 (magenta). Backbone-backbone hydrogen-bonding interactions are shown as dashed grey lines. Below is
the same, shown as a schematic.
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R341 corresponds to Eco
TRCF–RID
L499, which is critical for the TRCF/RNAP
protein/protein interaction (8), but is poorly conserved,
as is one of the residues it interacts with, RNAP-b
Q99
(Figure 2A). Examination of the sequence alignment,
however, reveals a strong correlation between the
identity of these two residues (corresponding to
Tth TRCF–RID
R341 and Tth RNAP-b
Q99) across phyla
(Figure 2A, columns highlighted in cyan and green).
Figure 2A shows a limited set of 21 sequences, but the
rules denoted below were determined from a more exten-
sive alignment containing more than 100 sequences from
actinobacteria, cyanobacteria, deinococcus-thermus,
ﬁrmicutes, fusobacteria, planctomycetes, proteobacteria
and spirochaetes:
(i) If the TRCF–RID has an R at this position, then
the RNAP-b1 has a Q, E or D at this position. So,
for example, Tth TRCF–RID
341 is R, Tth
RNAP-b
99 is Q. All of the Deinococcus–Thermus
and virtually all of the Actinobacteria have R in
the TRCF–RID (a handful have Q, one has K,
one has E). R does not occur at this position in
any other phylum examined.
(ii) If the TRCF–RID has a hydrophobic residue (either
F, I, L, M or V) or E or H at this position, then the
RNAP-b1 has an R or K (i.e. Eco TRCF–RID
L499,
Eco RNAP-b1
R101).
This suggests that conceptually, the TRCF–RID/
RNAP-b1 interface can be thought of as bipartite. A
central, relatively conserved set of contacts across the
intermolecular b-sheet, primarily between TRCF–RID
b-strand 4 and RNAP-b1 b-strand 4 is relatively
conserved across all phyla. On the other hand, a periph-
eral interaction between residues corresponding to
Tth TRCF–RID
R341 and Tth RNAP-b1
Q99 may occur in
a phylum-speciﬁc manner.
This hypothesis makes four predictions for the results of
single amino acid substitutions in the Thermus or Eco
proteins:
(1) The substitution Tth TRCF–RID
R341L should
disrupt the interaction with Tth RNAP-b1 but
improve the interaction with Eco RNAP-b1.
(2) The substitution Eco TRCF–RID
L499R should
disrupt the interaction with Eco RNAP-b1 but
improve the interaction with Tth RNAP-b1.
(3) The substitution Tth RNAP-b1
Q99R should disrupt
the interaction with Tth TRCF–RID but improve
the interaction with Eco TRCF–RID.
(4) The substitution Eco RNAP-b1 R101Q or R101E
should disrupt the interaction with Eco TRCF–RID
but improve the interaction with Tth TRCF–RID.
We tested these predictions using the bacterial two-hybrid
assay with the individual protein domains (TRCF–RID
and RNAP-b1; Figure 4A). The bacterial two-hybrid
assay previously established the minimal domains
required for the TRCF/RNAP protein/protein inter-
action, and demonstrated that single amino acid substitu-
tions in either the TRCF–RID or the RNAP-b1 domains
disrupt the interaction (8). The results show that predic-
tions 1–3 are fulﬁlled (Figure 4B–D, Supplementary
Figure S3B and C), and prediction 4 is partially fulﬁlled
(Supplementary Figure S3D):
Prediction (1) The substitution Tth TRCF–RID
R341L
improves the interaction with the heterologous Eco
RNAP-b1 more than 2-fold (Figure 4B, compare
lanes 1 and 2). At the conditions of this experiment
(50mM IPTG), there is no apparent defect in the
interaction of Tth TRCF–RID
R341L with Tth
RNAP-b1 (Figure 4B, lanes 4 and 5), but an
 2-fold defect is revealed when no IPTG is used
(Supplementary Figure S3B, lanes 1 and 2), where
leaky expression results in very low concentrations
of the binding partners.
Prediction (2) The substitution Eco TRCF–RID
L499R
improves the interaction with the heterologous Tth
RNAP-b1 (Figure 4C, lanes 1 and 2), and causes a
dramatic defect ( 10-fold) in binding to Eco
RNAP-b1 (Figure 4C, lanes 4 and 5), as observed
previously earlier (8).
Prediction (3) The substitution Tth RNAP-b1
Q99R
improves the interaction with the heterologous Eco
TRCF–RID  2-fold (Figure 4D, lanes 1 and 2). At
the conditions of this experiment (50mM IPTG),
there is no apparent defect in the interaction of Tth
RNAP-b1
Q99R with Tth TRCF–RID (Figure 4B,
lanes 4 and 5), but an  2-fold defect is revealed
when no IPTG is used (Supplementary Figure S3C,
lanes 1 and 2).
Prediction (4) The substitutions Eco RNAP-b1 R101Q
or R101E cause dramatic ( 5-fold) defects in
binding to the Eco TRCF–RID (Supplementary
Figure S3D, lanes 5–7), but under no conditions
did these substitutions improve the interaction with
the heterologous Tth TRCF–RID (Supplementary
Figure S3D, lanes 1–3).
DISCUSSION
The speciﬁc protein/protein interaction between TRCF
and RNAP is key to TRCF function and regulation in
bacterial TCR. TRCF does not recognize DNA damage
per se, it recognizes sites of DNA damage by proxy
through the protein/protein interaction with elongating
RNAP stalled at sites of damage. Furthermore, the
TRCF/RNAP protein/protein interaction is thought to
trigger the conformational changes in TRCF that are ne-
cessary for derepression of key TRCF activities, UvrA
binding and ATP-dependent DNA translocase activity
(8,12,13). Finally, the TRCF/RNAP protein/protein inter-
action provides an anchor point for TRCF on RNAP,
allowing the TRCF DNA-tracking translocation activity
to exert forces on the DNA that are ultimately responsible
for releasing the RNAP from the DNA template and
RNA transcript, enabling NER (15). In this work, the
structural basis for the TRCF/RNAP protein/protein
interaction has been elucidated with the 2.9-A ˚ resolution
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ing domains (the TRCF–RID and the RNAP-b1 domain)
necessary and sufﬁcient for the protein/protein
interaction.
The structural details of the complex explain many
aspects of previous mutagenesis data for both binding
partners. An amino acid substitution was identiﬁed
within the Eco TRCF–RID, L499R, that abolished an
activity of TRCF essential for the displacement of
stalled elongating RNAP, but did not abolish DNA
binding, ATP binding or ATP-hydrolysis (8). The
simplest interpretation of these results was that the
L499R substitution disrupted the protein/protein inter-
action between the TRCF–RID and the RNAP. This in-
terpretation was supported by previous bacterial
two-hybrid experiments (8) as well as in this work
(Figure 4C, compare lanes 4 and 5). In the structure
of the Tth TRCF–RID/Taq RNAP-b1 complex,
Tth TRCF–RID
R341 (corresponding to Eco TRCF–
RID
L499; Figure 2A) forms a hydrogen-bond with
RNAP-b1
Q99 as well as salt-bridge/hydrogen-bond inter-
actions with RNAP-b1
E110 (Figure 2B and C). Although
the residue at this position of the TRCF–RID (corres-
ponding to Tth TRCF–RID
341) is not conserved across
species, its identity is correlated with the RNAP-b1
residue corresponding to Tth RNAP-b1
99 (Figure 2A).
Amino acid substitutions were identiﬁed in three con-
secutive residues of RNAP-b1 that abrogated the RNAP
displacement function of TRCF. The effect of these sub-
stitutions was interpreted to mean that these three residues
participate in the TRCF/RNAP protein/protein inter-
action (14). This interpretation was supported by bacterial
two-hybrid experiments (8). In the structure of the Tth
TRCF–RID/Taq RNAP-b1 complex, these three
RNAP-b1 residues are central to the protein/protein inter-
face (Figure 2B and C). In addition to participating in
backbone hydrogen bonding that mediates the formation
of the intermolecular b-sheet (Figures 2B and C), the side
chain of I108 makes extensive van der Waals contacts with
TRCF–RID Y350 and Y362, the side chain of K109
makes van der Waals contacts with TRCF–RID residues
(primarily TRCF–RID
L361), and the side chain of E110
participates in polar interactions, primarily with TRCF–
RID
R341 (Figure 2B and C). Thus, qualitatively, the
ﬁnding that substitutions at these three positions of the
RNAP-b1 domain cause defects in the TRCF/RNAP
protein/protein interaction (8,14) is explained by the
structure.
Smith and Savery (14) found that substitutions in Eco
TRCF corresponding to Tth TRCF–RID I108A and
K109A had only mild effects on the TRCF/RNAP
Figure 4. Bacterial two-hybrid analysis of the interaction between
heterologous TRCF–RID and RNAP-b1 proteins. (A) Bacterial
two-hybrid assay (23,45) used to study the interaction between the
TRCF–RID and RNAP-b1 domains. Cartoon depicts how the inter-
action between protein domain X (fused to the N terminal domain of
the RNAP a-subunit, a-NTD) and protein domain Y (fused to the
bacteriophage   CI protein) activates transcription from test
promoter placOL262, which bears the   operator OL2 centered 62-bp
upstream of the start site of the lac core promoter. In reporter strain
FW102 OL262, test promoter placOL262 is located on an F0 episome
and drives the expression of a linked lacZ transcriptional fusion (8,45).
(B–D). Results of b-galactosidase assays performed with FW102 OL262
cells containing two compatible plasmids, one encoding either a ()o r
the indicated a fusion protein, and the other encoding  CI () or the
indicated  CI fusion protein. The plasmids directed the synthesis of a,
 CI, or the fusion proteins under the control of isopropyl-b-D-
thiogalactoside (IPTG)-inducible promoters and the cells were grown
in the presence of either 50mM IPTG (B, D) or 20mM IPTG (C).
Plotted on the graphs are the mean and SEM of four (B), six (C) or
12 (D) independent measurements.
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had a more severe effect. Quantitatively, these results are
more complicated to reconcile with the structure. Given
the extensive participation of RNAP-b1
I108 in van der
Waals contacts with TRCF (Figure 2B and C), one
might expect the I108A substitution to have a more
severe defect. Moreover, it is difﬁcult to see from the
structure why lysine is so relatively well conserved
at position 109. Also, despite the apparent importance
of RNAP-b1
E110, it is relatively poorly conserved
(Figure 2A). These observations may be reconciled,
however, by the ﬁnding that the RNAP-b1 undergoes a
local conformational change in the complex with the
TRCF–RID (Figure 3B–E). The conformational change
involves a register shift of RNAP-b1 b-strand 4 and
includes I108-E110. Thus, the effects of amino acid sub-
stitutions in this region of RNAP-b1 may affect the direct
interaction with the TRCF–RID, but can also inﬂuence
the interaction through its effect on the conformational
equilibrium of RNAP-b1 b-strand 4. An amino acid sub-
stitution in RNAP-b1 that favored the conformational
state of RNAP-b1 seen in the RNAP structures
(Figure 3D and E, left) over the state seen in the
complex with TRCF (Figure 3D, right) would introduce
an apparent defect in the interaction with TRCF by
reducing the population of RNAP competent to bind
TRCF, even if that residue did not directly contact
TRCF. In this case, it could be misleading to interpret
the results of mutagenesis studies on the TRCF/RNAP
protein/protein interaction by considering only the ﬁnal
TRCF–RID/RNAP-b1 structure.
The observed conformational change in RNAP-b1
raises another, more interesting issue; whether the con-
formational state of RNAP-b1 could be controlled
allosterically as a consequence of the functional state of
the RNAP. Could the TRCF-binding conformation of
RNAP-b1 be favored in stalled elongating RNAPs,
marking it as a target for TRCF function? A priori,
marking stalled elongating RNAPs is not necessary if
the rate of TRCF-mediated RNAP release is much
slower than elongation. In general, this appears to be
the case; TRCF-mediated RNAP release occurs on a
time scale of minutes (8,14,16), while nucleotide addition
by RNAP can occur on a time scale of milliseconds (29).
As a rule, then, TRCF would not be kinetically competent
to disrupt actively elongating RNAPs in vivo unless they
were stalled.
Several crystal structures of elongating Tth RNAP are
available. In one, the elongation complex was in the
post-translocated state, but transcription elongation was
stalled by nucleotide deprivation (30). In principal, such
an RNAP elongation complex stalled by nucleotide
deprivation would be subject to TRCF release (16), but
the conformational state of RNAP-b1 in both crystallo-
graphically independent complexes is essentially identical
to that observed in all other bacterial RNAP structures
(to date, more than 30 crystallographically independent
complexes), where RNAP-b1 is not in the TRCF-
binding conformation. Taken together, consideration of
kinetic parameters and available structural evidence
suggests that the conformational change in the
RNAP-b1 domain does not serve as an allosteric signal
for stalled RNAPs, but such a scenario cannot be com-
pletely ruled out. There may be situations in vivo, such as
at regulatory transcriptional pause sites (31), where the
kinetics of TRCF-mediated RNAP release could
compete with RNAP elongation, and TRCF-mediated
release of these paused elongation complexes might be
disadvantageous for the cells. From a structural view-
point, the conformational change in RNAP-b1 could con-
ceivably occur in an elongation intermediate that has not
been trapped in any crystal structures. The TRCF–RID/
RNAP-b1 structure presented here provides a basis for
designing experiments to address this question.
In addition to the previous mutagenesis studies of (14),
we tested additional amino acid substitutions at two pos-
itions (corresponding to Tth TRCF–RID
341 and Thermus
RNAP-b1
99) that are not conserved but appear to be
correlated with each other in a phylum-speciﬁc manner
(Figure 2A). As a rule, the cross-species interactions of
the wt Eco and Tth proteins were relatively weak
compared to the correct binding partners (Figure 4B–D,
compare lane 1 and 4). In three cases (Tth TRCF–
RID
R341L, Figure 4B; Eco TRCF–RID
L499R, Figure 4C;
Tth RNAP-b1
Q99R; Figure 4D), the predicted mutations
at the correlated positions improved the cross-species
interactions (Figure 4B–D, compare lane 1 and 2). In
one case (Eco RNAP-b1 R101Q or R101 E), the predicted
mutation had little effect (Supplementary Figure S3). In
this case, the effects of this substitution in the Eco
RNAP-b1 on the TRCF–RID/RNAP-b1 interaction
may be complicated by possible effects of the substitution
on the RNAP-b1 conformational change that occurs upon
TRCF–RID binding.
Using the apo-TRCF crystal structure, a model of the
RNAP TEC, and additional constraints, a preliminary
model for the TRCF/TEC assembly was constructed (8).
The model was preliminary since it was concluded that the
conformation of TRCF observed in the crystal structure
may not to correspond to the active conformation (8).
Indeed, it is now established that the conformation of
the apo-TRCF observed in the crystal structure corres-
ponds to a repressed state in which the UvrA binding de-
terminants are occluded, ATPase activity is very low, and
DNA translocase activity is essentially nonexistent
(12,13). Derepression of these TRCF activities is
expected to be associated with profound conformational
rearrangements of the TRCF domains with respect to
each other. It is thus not surprising that the orientation
of the TRCF–RID with respect to the RNAP-b1 domain
in the TRCF–RID/RNAP-b1 crystal structure is quite
different from the previous TRCF/TEC model
(Supplementary Figure S4). Because the conformation of
the derepressed TRCF associated with the TEC is
expected to be very different from the repressed conform-
ation of the TRCF crystal structure, it is not fruitful to
update the TRCF/TEC model by superimposing the RID
in the repressed TRCF crystal structure onto the RID
from the TRCF–RID/RNAP-b1 structure.
CarD has been identiﬁed as an essential Mtb protein
that is induced by DNA damage and starvation, and
controls rRNA transcription through a direct interaction
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two-domain protein (17) with an NTD with striking
sequence similarity to the TRCF–RID (19), and a
C-terminal domain of unknown structure. Moreover, the
TRCF–RID-like CarD-NTD is sufﬁcient for RNAP inter-
action, which, like the TRCF–RID, is targeted to the
RNAP-b1 domain (19). Thus, the Tth TRCF-RID/Taq
RNAP-b1 structure serves as an excellent model for
understanding the CarD/RNAP protein/protein
interaction.
A host of accessory factors directly interact with the
RNAP to modulate every step of the transcription cycle.
As the structural delineation of accessory factor/RNAP
interactions progresses, a handful of RNAP structural
features have emerged as regulatory ‘hot spots’, such as
the b-ﬂap [NusA (32); s factors (33–35); bacteriophage T4
AsiA (36); T4 gp33 (37); bacteriophage   Q (38)], the sec-
ondary channel [Gre-factors, (39–41); DksA (42,43)], and
the b0 clamp helices [s (34,35); RfaH (44)]. The interaction
of the RNAP-b1 domain with the TRCF–RID detailed
here, along with the analagous CarD–RID interaction,
point to the RNAP-b1 domain as another hot spot for
RNAP regulation.
The TRCF–RID/RNAP-b1 crystal structure presented
here reveals the structural details of the TRCF/RNAP
protein/protein interaction, which is key for TRCF
function and regulation. Structural analysis also reveals
a local conformational change in the RNAP-b1 in the
TRCF–RID-bound state. The effects of amino acid sub-
stitutions in RNAP-b1 on this conformational change
must be taken into account when interpreting the results
of protein interaction assays. This structure provides a
basis for the design and interpretation of experiments
probing TRCF and CarD function and interactions with
the RNAP.
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